Optional Treatment of Canine Transmissible Venereal Tumor (CTVT) by Combination of L-Asparaginase and Vincristine Sulphate
World Small Animal Veterinary Association World Congress Proceedings, 2015
C. Setthawongsin1; K. Sajjaviriyakul2; P. Teewasutrakul2; S. Techangamsuwan3; A. Rungsipipat3
1PhD Candidate Veterinary Pathobiology Program, Department of Veterinary Pathology, Chulalongkorn University, Bangkok, Thailand; 2Oncology Clinic Small Animal Teaching Hospital, Chulalongkorn University, Bangkok, Thailand; 3Companion Animal Cancer Research Unit, Department of Veterinary Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand


Canine transmissible venereal tumor (CTVT) is a naturally contagious tumor occurring at both genital (GTVT) and extragenital (ETVT) areas which are transmitted during coitus. Vincristine sulphate (VCL) is used as conventional chemotherapy for CTVT. Resistant VCL-treated CTVT can be occurred, then selective L-asparaginase was applied to these cases.


This study aimed to develop an optional treatment protocol for CTVT.


Six dogs (5 males and 1 female) with external genital mass were diagnosed as CTVT by cytology, histopathology and PCR, and treated with combined chemotherapeutic drugs, L-asparaginase at a dosage 200 IU/kg given subcutaneously at week 1 and 3, and VCL at a dosage 0.025 mg/kg given intravenously at week 2 and 4 at least 2 cycles.


All dogs showed complete remission within 4 weeks of treatment duration and did not show any adverse effects of drug toxicities (Figure 1).


Figure 1
Figure 1


Discussion and Conclusions

Combination chemotherapy (L-asparaginase and VCL), might be an optional chemotherapy in both GTVT, ETVT and resistant VCL-treated CTVT. This new protocol decreases treatment duration time and improve the quality of life in CTVT-bearing dogs.


Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

C. Setthawongsin
Veterinary Pathobiology Program
Department of Veterinary Pathology
Chulalongkorn University
Bangkok, Thailand

MAIN : Oncology : Treatment of Canine Transmissible Venereal Tumor
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616



  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357